Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

86.11 -2.03 (-2.31%)
Streaming Delayed Price Updated: 2:21 PM EDT, Jun 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Edwards Lifesciences

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
Via Benzinga
American, Southwest, Alaska Report Today With Focus On Summer Travel Demand
It’s a busy day for the airlines as three major carriers report and investors wait to hear what they might say about summer travel trends. In the meantime, broader market... 
Via Benzinga
Stock Market Rally Retreats, Bitcoin Dives Amid Biden Capital Gains Tax Plan; Netflix, Snap, United Airlines In Focus
The stock market rally fell modestly with President Biden set to propose a big capital gains tax hike on the wealthy. Bitcoin plunged below $50,000. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
48 Biggest Movers From Yesterday
Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company. Skillz Inc. (NYSE:... 
Via Benzinga
The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 21) Alexion Pharmaceuticals,... 
Via Benzinga
Does Biogen Stand A Chance Of Topping Bearish First-Quarter Views?
Biogen stock could enjoy some upside Thursday if it outperforms Wall Street's bearish expectations for steep declines in first-quarter sales and earnings. 
Via Investor's Business Daily
33 Stocks Moving In Wednesday's Mid-Day Session
Gainers Welbilt, Inc. (NYSE: WBT) shares jumped 34.8% to $21.06 after The Middleby Corporation announced plans to acquire the company. Acme United Corporation (NYSE: ACU) gained... 
Via Benzinga
Price Over Earnings Overview: Edwards Lifesciences
In the current session, Edwards Lifesciences Inc. (NYSE:EW) is trading at $93.45, after a 4.33% increase. Over the past month, the stock increased by 16.46%, and in... 
Via Benzinga
24 Stocks Moving in Wednesday's Pre-Market Session
Gainers Welbilt, Inc. (NYSE: WBT) shares rose 15.4% to $18.03 in pre-market trading after The Middleby Corporation announced plans to acquire the company. Alterity Therapeutics... 
Via Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,... 
Via Benzinga
Edwards Lifesciences Corp (EW) Q1 2021 Earnings Call Transcript
EW earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
8 Stocks Moving In Tuesday's After-Hours Session
Gainers Intuitive Surgical (NASDAQ: ISRG) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. Tenet Healthcare (NYSE: THC) shares... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up... 
Via Benzinga
Edwards Lifesciences: Q1 Earnings Insights
Shares of Edwards Lifesciences (NYSE:EW) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 64.24% year over... 
Via Benzinga
Edwards Adds To Its Breakout After Smashing First-Quarter Estimates
Edwards Lifesciences on Tuesday reported adjusted earnings of 54 cents per share on $1.22 billion in sales for the first quarter. EW stock jumped. 
Via Investor's Business Daily
The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Alexion Pharmaceuticals,... 
Via Benzinga
Edwards Lifesciences's Earnings Outlook
Edwards Lifesciences (NYSE:EW) releases its next round of earnings this Tuesday, April 20. Get the latest predictions in Benzinga's essential guide to the company's Q1... 
Via Benzinga
Earnings Scheduled For April 20, 2021
Companies Reporting Before The Bell • GATX (NYSE:GATX) is projected to report quarterly earnings at $0.85 per share on revenue of $303.17 million. • Simmons First... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.